ENTA Quote, Trading Chart, Enanta Pharmaceuticals Inc.
home / stock / enta / enta quote
$ Last:
Change Percent:
$ Open:
$ Previous Close:
$ High:
$ Low:
0 Volume:
01/01/1970 12:00:00 am Last Trade Date Time:
Quotes are delayed by 15 to 20 minutes.
Last Five Trading Days
| Stock Date | Open Price | Close Price | High | Low | Volume |
|---|---|---|---|---|---|
| 2021-03-02 | 49.55 | 49.92 | 50.22 | 48.04 | 663,253 |
| 2021-03-01 | 49.58 | 49.73 | 50.33 | 48.32 | 172,161 |
| 2021-02-26 | 50.03 | 49.32 | 51.06 | 47.955 | 279,049 |
| 2021-02-25 | 51.55 | 50.58 | 52.41 | 49.545 | 100,665 |
| 2021-02-24 | 52.255 | 51.72 | 52.28 | 51.22 | 98,441 |
| 2021-02-23 | 50.78 | 51.44 | 52.41 | 50.045 | 158,120 |
| 2021-02-22 | 52.02 | 51.16 | 52.81 | 51.005 | 137,039 |
| 2021-02-19 | 51.8 | 52.37 | 54.04 | 50.76 | 143,657 |
| 2021-02-18 | 52.27 | 51.71 | 52.73 | 50.98 | 157,388 |
| 2021-02-17 | 50.55 | 52.51 | 52.71 | 49.93 | 135,433 |
| 2021-02-16 | 51.13 | 50.24 | 51.13 | 49.37 | 162,943 |
| 2021-02-15 | 53.93 | 51.32 | 54.275 | 51.01 | 116,597 |
| 2021-02-12 | 53.93 | 51.32 | 54.275 | 51.01 | 116,597 |
| 2021-02-11 | 54.25 | 53.83 | 55.88 | 53.18 | 164,806 |
| 2021-02-10 | 55.09 | 54.12 | 55.91 | 53.05 | 153,482 |
| 2021-02-09 | 55.58 | 54.73 | 56.97 | 54.62 | 141,507 |
| 2021-02-08 | 53.45 | 54.95 | 55.55 | 52.76 | 120,933 |
| 2021-02-05 | 52.98 | 53.09 | 53.3 | 51.22 | 91,684 |
| 2021-02-04 | 52.95 | 52.6 | 53.77 | 52.34 | 131,732 |
| 2021-02-03 | 51.15 | 52.8 | 53.47 | 51.15 | 202,473 |
Enanta Pharmaceuticals Inc. Company Name:
ENTA Stock Symbol:
NASDAQ Market:
Enanta Pharmaceuticals Inc. Website:
News, Short Squeeze, Breakout and More Instantly...
-
Enanta Pharmaceuticals, Inc. (NASDAQ: ENTA), a clinical-stage biotechnology company dedicated to creating small molecule drugs for viral infections and liver diseases, today announced that Jay R. Luly, Ph.D., President and Chief Executive Officer, will present at the SVB Leerink 10 th...
-
Image source: The Motley Fool. Enanta Pharmaceuticals Inc (NASDAQ: ENTA) Q1 2021 Earnings Call Feb 8, 2021 , 4:30 p.m. ET Operator Continue reading For further details see: Enanta Pharmaceuticals Inc (ENTA) Q1 2021 Earnings Call Transcrip...
-
Broadened Hepatitis B Virus (HBV) Program with EDP-721, a New Oral HBV RNA Destabilizer, as a Potential Component of a Functional HBV Cure Regimen; Plan to Initiate Phase 1 Study Mid-2021 Initiated RSVTx, a Phase 2b Study of EDP-938 in Adult Hematopoietic Cell Transplant Rec...